Company Releases

NATROX Wound Care® Symposium

Exploring Patient-Centered Benefits: The Value of Continuous Topical Oxygen Therapy (cTOT) Wednesday 26 May at 4:00 p.m. Room #122 Speakers: Dr Windy Cole …

Inotec AMD Appoints Gordie Nye as Chairman of the Board

Inotec AMD, the leading innovator in continuous topical oxygen therapy (cTOT) for advanced wound care and parent company of NATROX® …

Inotec AMD Appoints Stefanie Brown Hawkins as CFO to Drive Strategic Growth and Innovation

[Cambridge, 16 December 2024] – Inotec AMD, the leading innovator in continuous topical oxygen therapy (cTOT) for advanced wound care …

QIAGEN launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data

• Ingenuity Pathway Analysis Interpret extends analysis capabilities of human-curated knowledge base with AI technology • AI-extension highlights key biological elements at …

Inotec Secures $33 Million in Series C Financing to Accelerate US Expansion

Inotec AMD, whose product NATROX® O₂ is the leader in continuous topical oxygen therapy (cTOT) for advanced wound care, today …